Xtent Inc. Sets IPO At 4.7 Million Shares, $16-$18 Each
1/11/2007 8:13:01 AM
WASHINGTON, Jan 11 (Reuters) - Xtent Inc., which develops stent systems to treat coronary artery disease, on Thursday set its planned initial public offering at 4.7 million shares for an estimated price of $16 to $18 each.
>>> Discuss This Story
comments powered by